JPRN-UMIN000044057
Completed
Phase 2
Clinical trial to examine the safety of early removal of chest tube after thoracic surgery - Clinical trial to examine the safety of early removal of chest tube after thoracic surgery
Social Welfare Organization Saiseikai Imperial Gift Foundation, Inc.0 sites151 target enrollmentApril 27, 2021
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Social Welfare Organization Saiseikai Imperial Gift Foundation, Inc.
- Enrollment
- 151
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patients scheduled for surgery with resection of the lung parenchyma show severe emphysematous changes and interstitial lung disease in the remaining lungs on preoperative imaging. 2\. Patients who require combined resection and / or reconstruction of adjacent organs / structures such as the rib cage and diaphragm. 3\. Patients who require continuous chest tube drainage after surgery, such as empyema. 4\. Patients with high\-risk factors for bleeding (patients with hemorrhagic disease, patients taking antithrombotic / anticoagulant) or with chest trauma that require observation of postoperative bleeding. 5\. Other patients whose participation in this study was judged to be inappropriate by the surgeon.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 1
A Phase I clinical trial to investigate the safety and tolerability of NK105 when co-administered with carboplatin once per week to Japanese patients with advanced solid cancers.Advanced solid cancersJPRN-jRCT2080223202ippon Kayaku Co., Ltd.18
Recruiting
Not Applicable
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma PatientsNeoplasmsKCT0002244Dong-A ST32
Active, not recruiting
Phase 1
A study to compare two dosing regimens for a new malaria vaccineMalaria (African strain)Infections and InfestationsISRCTN95289709niversity of Oxford23
Recruiting
Phase 1
Cell Therapy for back paiHealth Condition 1: M511- Thoracic, thoracolumbar and lumbosacral intervertebral disc disorders with radiculopathyCTRI/2024/07/069696Samarthakrupa LIfesciences Pvt Ltd
Active, not recruiting
Phase 1
A Phase I clinical trial to assess the safety and immunogenicity of HIV DNA immunisations administered via the Intramuscular and Intradermal methods with and without electroporation followed by boosting with recombinant HIV protein in healthy male and female volunteersHIV prophylaxisMedDRA version: 18.0 Level: PT Classification code 10020161 Term: HIV infection System Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2015-001023-23-GBImperial College London28